Form 4: Avalon Ventures XI, L.P. Sells Janux Therapeutics Shares
SEC Form 4
Avalon Ventures XI, L.P., along with related entities, sold shares of Janux Therapeutics (JANX) between September 10 and September 12, 2024.
Summary
- Avalon Ventures XI, L.P. and related entities, including Avalon BioVentures I, LP and Avalon BioVentures SPV I, LP, have reported the sale of Janux Therapeutics (JANX) common stock.
- The transactions occurred between September 10, 2024, and September 12, 2024.
- The sales were executed at prices ranging from $45.50 to $47.02 per share.
- Avalon Ventures XI, L.P. directly sold shares, while Avalon BioVentures I, LP and Avalon BioVentures SPV I, LP's sales were attributed to their direct holdings.
- Jay Lichter, through his roles in the general partners of these entities, shares voting and investment power but disclaims beneficial ownership except to the extent of his pecuniary interest.
- Following these transactions, Avalon Ventures XI, L.P. directly holds 2,959,175 shares, Avalon BioVentures I, LP holds 573,227 shares, and Avalon BioVentures SPV I, LP holds 3,021,414 shares.
Sentiment
Score: 5
Explanation: Neutral sentiment as it reflects standard insider selling activity. The sales themselves are neither overwhelmingly positive nor negative, but the market reaction will determine the ultimate impact.
Negatives
- Avalon Ventures XI, L.P. and related entities reduced their holdings in Janux Therapeutics.
Risks
- Continued selling pressure from major shareholders like Avalon Ventures could negatively impact the stock price.
Industry Context
Form 4 filings are standard disclosures for significant shareholders and insiders, providing transparency into their trading activities. These filings are closely watched by investors to gauge sentiment and potential future actions by major stakeholders.
Stakeholder Impact
- Shareholders may react to the news of Avalon Ventures selling shares, potentially impacting the stock price.
- The sales could influence investor confidence in Janux Therapeutics.
Key Dates
| Date | Description |
|---|---|
| 09/10/2024 | Date of initial share sale transactions. |
| 09/12/2024 | Date of final share sale transactions and filing date of the Form 4. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.